Data Element

Information from the submission form

Laboratory Result Status
The status of the laboratory result value.


Unified Comment from CDC

  • Additional Use Cases:
  • HIV, STDs, Viral Hepatitis and Tuberculosis are nationally notifiable diseases for which diagnosis is dependent upon laboratory results. As such, laboratory test performed date, result value and result status are collected as part of CDC's routine surveilannce for these conditions. Additionally, beyond diagnostic tests, additional laboratory test information is collected to understand the health status of patients (e.g. HIV viral load, liver enzymes), and trends in drug susceptibility.  
  • All of the laboratory data collected is used both for case management purposes within state, local, territorial and tribal health jurisdictions, and public health purposes at the national level. These data are integral to understanding disease transmission and to prioritize appropriate interventions for affecting communities.
  • Additional Use Case: This is a standard data item used by central cancer registries in all states. Data received through data exchange from pathology laboratories to central cancer registries for CDC and NCI’s national cancer surveillance systems, as required by law.  
  • Estimate number of stakeholders who capture, access, use or exchange this data element: All US States and DC are funded through CDC’s Division of HIV Prevention, Division of TB Elimination, Division of STD Prevention, and Division of Viral Hepatitis flagship Notice of Funding Actions to perform surveillance activities, including collection of these data for surveillance purposes.  
  • Healthcare Aims: Improving patient experience of care, Improving health of populations, Reducing cost of care, provider experience of care.  
  • Use of data element: Extensively used in production environments  
  • This element is used by CMS Quality Reporting and is marked Required or Must Support in the FHIR QI Core IG  
  • CSTE supports inclusion of this measure into USCDI v3

Additional Use Cases

I don't see Electronic Lab Reporting (ELR) mentioned in the above use case list - the v2 ELR R1 Implementation Guide ( has been a PH MU measure since Stage1 and is widely implemented across the nation - both Result (Observation) Status (OBX-11 in v2) and Result Status (OBR-25 in v2) are requried elements.

Suggest to include in USCDI v3 - with clarification

Clarifcation is needed as there are often 2 status elements used: A status at the level of the performed test (in v2 OBX-11, in C-CDA observation.statusCode and in FHIR observation.status) - assuming that is the minimum element needed. It is a CLIA required element. A status at the level of the order (in v2 OBR-25, in CDA Laboratory Battery Organizer.statusCode, in FHIR DiagnosticReport.status) indicating the status for all expected results for this battery. It is a CLIA required element.

Log in or register to post comments